Flumetasone Pivalate shortage status
1 active shortage notice across 1 country.
Last updated 2 Aug 2026 · sourced from official medicines regulators
- Generic name (INN)
- Flumetasone Pivalate
- Brand names
- Locorten-Vioform
- Class
- Auto-created by Pharmac — New Zealand Medicine Supply Disruptions scraper
Where Flumetasone Pivalate is in shortage
| Country | Severity | Notices | Since | Est. resolution | Source |
|---|---|---|---|---|---|
| New Zealand | high | 1 | 12 Mar 2026 | — | Pharmac |
Why Flumetasone Pivalate is in shortage
- supply-chain disruption — e.g. “Locorten-Vioform ear drops (Pharmacode 259799) will be out of stock until at least August 2026.” (New Zealand)
Frequently asked questions
Is Flumetasone Pivalate currently in shortage?
Yes. As of the latest regulator updates, Flumetasone Pivalate has 1 active shortage notice across 1 country (New Zealand). Status is refreshed daily from official regulatory sources.
Why is Flumetasone Pivalate in shortage?
Regulators attribute the current Flumetasone Pivalate shortages to supply-chain disruption. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Flumetasone Pivalate shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Flumetasone Pivalate status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.